New diagnostic test soon ready for the market

Lovande resultat för oral terapi vid atopiskt eksem

Bättre läkning av huden efter oral behandling, enligt nya studieresultat.

How to become globally competitive

Here Gunilla Osswald from BioArctic share her experience of scaling up and be competative on the global arena.

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Start up-bolag får kapital

Vinnova har delat ut årets Vinn nu-pengar.

EUR 2 million for peanut allergies

ALK Abelló has signed an agreement to invest EUR 2 million in the French biotechnology company DBV Technologies.

Lucka 15 - se vem du hittar här

Denna välkända branschprofil önskar ta med sig framgångarna från Sverige till Hongkong och USA...

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

Ondosis hittar samarbete om ADHD-behandling

Ska skapa en formulering för den amerikanska marknaden.

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”

When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, abou...

Läkemedelsjättar investerar i start up-bolag

Nybildade Galecto får stöd från Novo och Merck.

QureTech vinner pitchtävling

Umeåbolaget blev vinnare i tävlingen Start-up Slam som hölls under det internationella mötet Bio-Europe Spring, som gick av stapeln på Kistamässan.

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

Björn Arvidsson: Osjälviska aktörer framgångsrika i ekosystemen

“Berusad” efter att ha deltagit i eventet Uppsala Life som samlade 300 deltagare i Uppsala-regionen för att diskutera förutsättningar för framgångsrik life scie...

Nyckelperson till GU ventures

Magdalena Rosinski har anslutit till GU ventures inkubatorsverksamhet.

Teams up with leading dermatologist

Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Sana Alajmovic: ”Vi måste tala om de stora visionerna – bygga nästa Astra”

Sigrid Terapeutics grundare och vd, Sana Alajmovic, hamnade på listan Framtidens kvinnliga ledare.